科研成果详情

题名miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer
作者
发表日期2019-05-08
发表期刊CELL DEATH & DISEASE   影响因子和分区
语种英语
原始文献类型Article
其他关键词EPITHELIAL-MESENCHYMAL TRANSITION ; PROTEIN FHL2 ; SCAFFOLD PROTEIN ; DNA METHYLATION ; BETA-CATENIN ; TUMOR-GROWTH ; EXPRESSION ; INTERACTS ; MICRORNAS ; DIFFERENTIATION
摘要Although increasing evidence indicated that deregulation of microRNAs (miRNAs) contributed to tumor initiation and progression, but little is known about the biological role of miR-340 in ovarian cancer (OC). In this study, we found that miR-340 expression was downregulated in OC tissues compared with its expression in normal ovarian epithelium and endometrium, and treatment with 5-aza-2'-deoxycytidine (5-Aza-dC) or trichostatin A (TSA) increased miR-340 expression in OC cells. In addition, ectopic miR-340 expression inhibited OC cell growth and metastasis in vitro and in vivo. Four and a half LIM domains protein 2 (FHL2) was confirmed as a direct target of miR-340 and silencing FHL2 mimicked the effects of miR-340 in OC cells. Further mechanistic study showed that miR-340 inhibited the Wnt/beta-catenin pathway by targeting FHL2, as well as downstream cell cycle and epithelial-to-mesenchymal transition (EMT) signals in OC cells. Moreover, the greatest association between miR-340 and FHL2 was found in 481 ovarian serous cystadenocarcinoma tissues via pan-cancer analysis. Finally, we revealed that lower miR-340 or higher FHL2 was associated with poor OC patient outcomes. Our findings indicate that the miR-340-FHL2 axis regulates Wnt/beta-catenin signaling and is involved in tumorigenesis in OC. Therefore, manipulating the expression of miR-340 or its target genes is a potential strategy in OC therapy.
资助项目National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC-81472651, 81201589]
出版者NATURE PUBLISHING GROUP
出版地LONDON
ISSN2041-4889
卷号10期号:5页码:372
DOI10.1038/s41419-019-1604-3
页数16
WOS类目Cell Biology
WOS研究方向Cell Biology
WOS记录号WOS:000468670100006
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID31068580
PMC记录号PMC6506554
SCOPUSEID2-s2.0-85065442875
通讯作者地址[Wu, Jianmin]Institute of Genomic Medicine,Wenzhou Medical University,Wenzhou,325000,China
Scopus学科分类Immunology;Cellular and Molecular Neuroscience;Cell Biology;Cancer Research
TOP期刊TOP期刊
引用统计
被引频次:27[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/12258
专题基因组医学研究院
附属第二医院
第二临床医学院、附属第二医院、育英儿童医院_妇产科学
附属第二医院_妇产科
通讯作者Wu, Jianmin
作者单位
1.Institute of Genomic Medicine,Wenzhou Medical University,Wenzhou,325000,China;
2.Department of Obstetrics and Gynecology,The Second Affiliated Hospital and Yuying Children of Wenzhou Medical University,Wenzhou,325027,China
第一作者单位基因组医学研究院
通讯作者单位基因组医学研究院
第一作者的第一单位基因组医学研究院
推荐引用方式
GB/T 7714
Huang, Zheng,Li, Qiuxia,Luo, Kaili,et al. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer[J]. CELL DEATH & DISEASE,2019,10(5):372.
APA Huang, Zheng., Li, Qiuxia., Luo, Kaili., Zhang, Qinkai., Geng, Jingwen., ... & Wu, Jianmin. (2019). miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. CELL DEATH & DISEASE, 10(5), 372.
MLA Huang, Zheng,et al."miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer".CELL DEATH & DISEASE 10.5(2019):372.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Huang, Zheng]的文章
[Li, Qiuxia]的文章
[Luo, Kaili]的文章
百度学术
百度学术中相似的文章
[Huang, Zheng]的文章
[Li, Qiuxia]的文章
[Luo, Kaili]的文章
必应学术
必应学术中相似的文章
[Huang, Zheng]的文章
[Li, Qiuxia]的文章
[Luo, Kaili]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。